These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23078778)

  • 41. A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil HPV vaccine in mice.
    Han JE; Kim HK; Park SA; Lee SJ; Kim HJ; Son GH; Kim YT; Cho YJ; Kim HJ; Lee NG
    Int Immunopharmacol; 2010 Feb; 10(2):169-76. PubMed ID: 19874917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli.
    Wang D; Fan F; Li Z; Liu X; Song S; Wei S; He M; Lin Y; Li Z; Wei M; Yu H; Gu Y; Li S; Xia N
    Protein Expr Purif; 2017 May; 133():110-120. PubMed ID: 28267627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and safety of quadrivalent human papillomavirus types 6/11/16/18 recombinant vaccine in chronic kidney disease stage IV, V and VD.
    Praditpornsilpa K; Kingwatanakul P; Deekajorndej T; Rianthavorn P; Susantitaphong P; Katavetin P; Tiranathanakul K; Srisawat N; Tungsanga K; Eiam-Ong S; Townamchai N
    Nephrol Dial Transplant; 2017 Jan; 32(1):132-136. PubMed ID: 26932687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.
    Zhai L; Peabody J; Pang YS; Schiller J; Chackerian B; Tumban E
    Antiviral Res; 2017 Nov; 147():116-123. PubMed ID: 28939477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.
    Struyf F; Colau B; Wheeler CM; Naud P; Garland S; Quint W; Chow SN; Salmerón J; Lehtinen M; Del Rosario-Raymundo MR; Paavonen J; Teixeira JC; Germar MJ; Peters K; Skinner SR; Limson G; Castellsagué X; Poppe WA; Ramjattan B; Klein TD; Schwarz TF; Chatterjee A; Tjalma WA; Diaz-Mitoma F; Lewis DJ; Harper DM; Molijn A; van Doorn LJ; David MP; Dubin G;
    Clin Vaccine Immunol; 2015 Feb; 22(2):235-44. PubMed ID: 25540273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gardasil: Introducing the new human papillomavirus vaccine.
    McLemore MR
    Clin J Oncol Nurs; 2006 Oct; 10(5):559-60. PubMed ID: 17063609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.
    Chen Z; Jing Y; Wen Q; Ding X; Zhang S; Wang T; Zhang Y; Zhang J
    Virol J; 2016 Oct; 13(1):167. PubMed ID: 27717385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.
    Lee SH; Vigliotti VS; Pappu S
    J Clin Pathol; 2010 Mar; 63(3):235-9. PubMed ID: 19858529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A teat papillomatosis case in a Damascus goat (Shami goat) in Hatay province, Turkey: a new putative papillomavirus?
    Dogan F; Dorttas SD; Bilge Dagalp S; Ataseven VS; Alkan F
    Arch Virol; 2018 Jun; 163(6):1635-1642. PubMed ID: 29502149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
    Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
    Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?
    Petersen SB; Gluud C
    BMJ Evid Based Med; 2021 Dec; 26(6):285-289. PubMed ID: 32763959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus.
    Micalessi MI; Boulet GA; Vorsters A; De Wit K; Jannes G; Mijs W; Ieven M; Van Damme P; Bogers JJ
    J Virol Methods; 2013 Jan; 187(1):166-71. PubMed ID: 23018060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
    Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The analysis of human papillomavirus type 16 E6/E7 genetic variability in Yunnan Province, China].
    Yang LJ; Yue YF; Chen JY; Pan Y; Zhao YJ; Ma SH; Sun QM
    Bing Du Xue Bao; 2012 Nov; 28(6):645-51. PubMed ID: 23367564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.
    Toft L; Storgaard M; Müller M; Sehr P; Bonde J; Tolstrup M; Østergaard L; Søgaard OS
    J Infect Dis; 2014 Apr; 209(8):1165-73. PubMed ID: 24273179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania.
    Bolhassani A; Muller M; Roohvand F; Motevalli F; Agi E; Shokri M; Rad MM; Hosseinzadeh S
    Hum Vaccin Immunother; 2014; 10(12):3499-508. PubMed ID: 25668661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel fluorescence polarization based assay for 14 human papillomavirus genotypes in clinical samples.
    Zhang J; Chen Z; Gao Y; Jiang Y; Xia L; Guo Y; Yan X
    J Virol Methods; 2006 Jun; 134(1-2):223-9. PubMed ID: 16488487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.
    Herrin DM; Coates EE; Costner PJ; Kemp TJ; Nason MC; Saharia KK; Pan Y; Sarwar UN; Holman L; Yamshchikov G; Koup RA; Pang YY; Seder RA; Schiller JT; Graham BS; Pinto LA; Ledgerwood JE
    Hum Vaccin Immunother; 2014; 10(12):3446-54. PubMed ID: 25483691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The aetiological role of human papillomavirus in colorectal carcinoma: an Iranian population- based case control study.
    Ranjbar R; Saberfar E; Shamsaie A; Ghasemian E
    Asian Pac J Cancer Prev; 2014; 15(4):1521-5. PubMed ID: 24641361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions.
    Hirai R; Makiyama K; Matsuzaki H; Oshima T
    J Voice; 2018 Jul; 32(4):488-491. PubMed ID: 28866231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.